Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research¸ a journal of the American organization for Cancer Research. Original post...

CV Therapeutics, Inc. (Nasdaq: CVTX) announced that preclinical research presented at the American College of Cardiology 57th Annual Scientific Session in Chicago showed that ranolazine increased glucose-stimulated insulin secretion (GSIS) in pancreatic islets loney from animals and humans. Original...

The results of the landmark ONTARGET(TM) trial have demonstrated that MICARDIS(R) (telmisartan), a second-generation angiotensin II receptor blocker (ARB), is equally effective as the current standard, ramipril, in reducing the risk of cardiovascular death, myocardial infarction, stroke Original post...

Interim results from the achieve (Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension) trial demonstrate that high-risk, high blood pressure patients treated with Lotrel(R) (amlodipine besylate and benazepril HCl) had 20% fewer cardiovascular events...

New goods from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS(R) (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline. These input...

Boston Scientific Corporation (NYSE: BSX) welcomed positive two-year results from Abbott’s prospective, randomized (3:1), one blind, non-inferiority SPIRIT II Trial comparing the safety and efficacy of the XIENCE(TM) V (PROMUS(TM)) Everolimus-Eluting Coronary Stent and Boston Scientific’s...

Synvista Therapeutics, Inc. (Amex: SYI) announces details from a study of diabetic mice with the Haptoglobin 2-2 genotype that show impairment in the clearance of the Haptoglobin (Hp)-Hemoglobin (Hb) complex may aftereffect in a modification of high-density lipoprotein (HDL) structure and faulty reverse...

CV Therapeutics, Inc. (Nasdaq: CVTX) announced that ranolazine significantly (p Original post by Women’s Health / Gynecology News From Medical News Today

Fasting for two days protects healthy cells against chemotherapy, according to a study appearing online the week of Mar. 31 in PNAS Early Edition.Mice given a high dose of chemotherapy after fasting continued to thrive. The same dose killed half the normally fed mice and caused lasting weight and energy...

One group of small, non-coding RNA molecules could serve as a marker to improve cancer staging and may additionally be able to convert some advanced tumors to more treatable stages, report a University of Chicago-based research team in the April 1, 2008, issue of the journal Genes & Development.Carcinomas...

Acupressure pursues the similar technique as that of acupuncture points. On the acupuncture point or whole body, firm and regular pressure is applied physically with the help of your elbow, hand or any other device called as the acupressure. You should rub rapidly on acupressure point, as these points...